Skip to main content
. Author manuscript; available in PMC: 2020 May 18.
Published in final edited form as: Br J Nutr. 2017 Jun 13;117(10):1470–1477. doi: 10.1017/S0007114517001325

Table 2:

Baseline characteristics of the cohort stratified by quintiles of total-flavonoid consumption1

Quintile 1 Quintile 3 Quintile 5
< 150 mg/d 222 – < 329 mg/d ≥ 587 mg/d
Number 18 617 18 612 18 651
Demographic variables
 Age (years)2 36.0 ± 4.7 36.0 ± 4.7 36.5 ± 4.6
 Body mass index (kg/m2) 25.0 ± 5.7 24.4 ± 5.1 24.7 ± 5.3
 Caucasian (%) 93.1 93.6 94.7
 Current smoker (%) 18.1 9.9 11.3
 Postmenopausal (%) 3.2 3.1 3.9
 Physical activity (MET-hrs/wk)3 16.8 ± 24.2 22.6 ± 28.1 21.6 ± 28.8
Prevalent disease
 Type 2 diabetes (%) 1.0 1.0 1.0
 Hypercholesterolemia (%) 11.3 10.1 10.9
 Hypertension (%) 6.4 6.0 7.0
Family history of disease
 Diabetes (%) 17.2 16.0 17.4
 Myocardial infarction (%) 22.7 20.7 22.2
 Cancer(%) 22.7 22.9 22.2
Dietary intake and medications
 Current Aspirin use (%) 11.7 10.7 12.0
 Current multivitamin use (%) 38.6 47.1 42.7
 Calorie intake (Kcal/d) 1 703.2 ± 540.8 1 851.4 ± 548.5 1 735.4 ± 565.7
 Alcohol intake (g/d) 3.1 ± 6.4 3.3 ± 5.9 2.6 ± 5.6
 AHEI (score)4 40.8 ± 10.1 45.5 ± 10.4 44.9 ± 10.5
1

Results are mean ± SD or percentage where appropriate. Values standardized to the age distribution of the study population. Flavonoid consumption is standardized to total-energy intake. n = 93,145;

2

Value is not age adjusted;

3

Met: metabolic equivalent;

4

AHEI: Alternative Healthy Eating Index (excluding alcohol) score.